《2012北美絕經學會激素治療立場聲明》內容預覽
Objective: This position statement aimed to update the evidence-based position statement published by The North American Menopause Society (NAMS) in 2010 regarding recommendations for hormone therapy (HT) for postmenopausal women. This updated position statement further distinguishes the emerging differences in the therapeutic benefit-risk ratio between estrogen therapy (ET) and combined estrogen-progestogen therapy (EPT) at various ages and time intervals since menopause onset.
《2012北美絕經學會激素治療立場聲明》完整版下載地址:
http://ziyuan.iiyi.com/source/down/1448613.html